小细胞肺癌分子标志物PARP1的研究进展(4)
[22] Fong PC，Yap TA，Boss DS，et al. Poly(ADP)-ribose polymerase inhibition：frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval [J]. J Clin Oncol，2010，28(15)：2512-2519.
[23] Lally E，Urbanic JJ，Blackstock AW，et al. Small cell lung cancer：have we made any progress over the last 25 years？ [J]. Oncologist，2007，12(9)：1096-1104.
[24] Delaney CA，Wang LZ，Kyle S，et al. Potentiation of temozolomide and topotecan growth inhibition and cytotoxicity by novel poly(adenosine diphosphoribose)polymerase inhibitors in a panel of human tumor cell lines [J]. Clin Cancer Res，2000，6(7)：2860-2867.
[25] Calabrese CR，Almassy R，Barton S，et al. Anticancer chemosensitization and radiosensitization by the novel poly(ADP-ribose)polymerase-1 inhibitor AG14361 [J]. J Natl Cancer Inst，2004，96(1)：56-67.
[26] Byers LA，Nilsson MB，Masrorpour F，et al. Investigation of PARP1 as a therapeutic target in small cell lung cancer. 2012 ASCO Annual Meeting [J]. J Clin Oncol， 2012，30(suppl)：7096.
(收稿日期：2012-10-24 本文编辑：谷俊英)
, 百拇医药(王露 朱哲慧 陈思敏 赖仁胜)
[23] Lally E，Urbanic JJ，Blackstock AW，et al. Small cell lung cancer：have we made any progress over the last 25 years？ [J]. Oncologist，2007，12(9)：1096-1104.
[24] Delaney CA，Wang LZ，Kyle S，et al. Potentiation of temozolomide and topotecan growth inhibition and cytotoxicity by novel poly(adenosine diphosphoribose)polymerase inhibitors in a panel of human tumor cell lines [J]. Clin Cancer Res，2000，6(7)：2860-2867.
[25] Calabrese CR，Almassy R，Barton S，et al. Anticancer chemosensitization and radiosensitization by the novel poly(ADP-ribose)polymerase-1 inhibitor AG14361 [J]. J Natl Cancer Inst，2004，96(1)：56-67.
[26] Byers LA，Nilsson MB，Masrorpour F，et al. Investigation of PARP1 as a therapeutic target in small cell lung cancer. 2012 ASCO Annual Meeting [J]. J Clin Oncol， 2012，30(suppl)：7096.
(收稿日期：2012-10-24 本文编辑：谷俊英)
, 百拇医药(王露 朱哲慧 陈思敏 赖仁胜)